BioCentury
ARTICLE | Clinical News

Introgen preclinical data

April 10, 2006 7:00 AM UTC

In a mouse model of human lung cancer, INGN-241 plus Avastin led to about 70% complete tumor regression, resulting in significantly improved survival vs. either agent alone or controls. Data were pre...